Yi-Ting Chen

Yi-Ting Chen is a highly skilled scientist currently working at BridgeBio since June 2023. Previously, Yi-Ting served as a Graduate Student Researcher at Baylor College of Medicine from August 2016 to March 2023, where significant contributions included discovering the role of ATRX in bone homeostasis and osteosarcoma through CRISPR gene editing and multi-omics approaches. Prior research experience includes serving as a Research Associate at Taipei Veterans General Hospital and National Taiwan University, focusing on triple-negative breast cancer, asthma, and colitis models. Yi-Ting earned a Doctor of Philosophy in Molecular Biology from Baylor College of Medicine and holds a Master of Science in Microbiology and Immunology and a Bachelor of Science in Medical Laboratory Science and Biotechnology from National Taiwan University and National Cheng Kung University, respectively.